NYSE$UNH

UnitedHealth · Q4 2020 earnings

Q4 2020 earnings · · Investor relations

Briefing

UnitedHealth Group's Q4 2020 results reflected strong performance, impacted by COVID-19 care costs and assistance initiatives.

UnitedHealth Group reported Q4 2020 revenues of $65.5 billion and net earnings per share of $2.30. The results were impacted by COVID-19 care costs and related assistance initiatives. The company affirmed its full year earnings outlook for 2021.

  • Full year revenues of $257.1 billion grew $15.0 billion or 6%, led by 21% at Optum.
  • Full year and fourth quarter net earnings per share of $16.03 and $2.30.
  • Full year and fourth quarter adjusted net earnings per share of $16.88 and $2.52.
  • Results reflect COVID-19 impacts and related assistance initiatives.

Headline financials

Total Revenue

$65.5B

Previous: $60.9B+7.5%
EPS (adj)

$2.52

Previous: $3.90-35.4%
Optum Health Consumers

98.0M

No prior period
Capital Expenditures

$574M

Previous: $650M-11.7%
Free Cash Flow

$5.53B

Previous: $5.56B-0.5%
Net Income

$2.35B

Previous: $3.67B-35.9%
Operating Income

$3.52B

Previous: $5.1B-31.0%
Gross Profit

$15.8B

Previous: $15.1B+4.3%
Cash & Equivalents

$16.9B

No prior period
Total Assets

$197B

No prior period
Stock-Based Comp

$152M

Previous: $172M-11.6%

Revenue & EPS history

UnitedHealth · Revenue · Quarterly

$65.5B

Q4 2020+7.5%vs Q4 2019
Beat estimate in 16 of 16 quarters(100%)
ActualEstimate

Revenue by segment

UnitedHealth · $65.5B total across 4 segments · Q4 2020

  • Premiums
    $50.6B
  • Products
    $8.69B
  • Services
    $5.75B
  • Investment & Other
    $445M

Forward guidance

The Company affirmed its recently issued full year earnings outlook for 2021, including net earnings of $16.90 to $17.40 per share and adjusted net earnings of $17.75 to $18.25 per share. As previously discussed, this outlook includes approximately $1.80 per share in potential net unfavorable impact to accommodate continuing COVID-19 effects, such as: testing and treatment costs; the residual impact of people deferring care in 2020; and unemployment and other economy-driven factors.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q4 2020

Historical avgQ4 2020

+0.9%

Avg return

Earnings day

+1.3%

Avg return

5 days after

+2.6%

Avg return

30 days after

63%

46 / 73 earnings

Positive

+11.2%

Q2 2024

Best reaction

-22.4%

Q1 2025

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026+0.2%+9.7%+18.1%
Q4 2025-11.2%-18.4%-18.5%
Q3 2025+0.1%-6.7%-9.9%
Q2 2025+0.6%+21.2%+38.2%
Q1 2025-22.4%-27.0%-50.1%
Q4 2024-6.2%-3.4%-3.7%
Q3 2024-5.6%-5.9%-2.0%
Q2 2024+11.2%+9.7%+12.5%
Q1 2024+7.5%+12.5%+17.0%
Q4 2023-3.8%-2.7%-4.0%
Q3 2023+2.4%+2.0%+3.0%
Q2 2023+8.1%+12.5%+13.5%
Q1 2023-4.0%-7.6%-6.7%
Q4 2022-2.1%-3.9%-0.3%
Q3 2022+2.3%+2.0%+2.4%
Q2 2022+3.4%+3.4%+8.2%
Q1 2022-0.5%+0.1%-9.6%
Q4 2021+0.4%+0.3%+1.5%
Q3 2021+6.1%+5.2%+13.7%
Q2 2021+1.2%-0.4%-1.2%
Q1 2021+4.1%+5.6%+9.1%
Q4 2020+0.8%-1.2%-7.8%
Q3 2020-2.1%-2.2%+7.3%
Q2 2020-0.4%-1.6%+4.9%
Q1 2020+10.3%+4.3%+7.6%
Q4 2019+4.3%+3.5%+3.7%
Q3 2019+7.4%+11.2%+16.0%
Q2 2019-3.8%-4.4%-7.9%
Q1 2019-5.8%-3.7%+2.9%
Q4 2018+5.4%+7.0%+7.0%
Q3 2018+2.7%+1.9%+1.8%
Q2 2018-0.6%-1.7%+2.4%
Q1 2018+2.6%+2.1%+5.5%
Q4 2017+4.3%+6.4%-1.1%
Q3 2017+6.2%+7.4%+9.3%
Q2 2017+1.5%+2.9%+3.4%
Q1 2017+1.2%+2.4%+2.6%
Q4 2016-2.5%-1.9%+1.1%
Q3 2016+7.6%+8.4%+12.4%
Q2 2016+1.6%+2.1%+1.0%
Q1 2016+4.8%
Q4 2015+5.1%
Q3 2015-1.7%
Q2 2015-1.6%
Q1 2015+1.2%
Q4 2014+7.8%
Q3 2014+7.3%
Q2 2014+2.1%
Q1 2014-4.1%
Q4 2013-3.1%
Q3 2013-8.6%
Q2 2013+7.9%
Q1 2013-3.2%
Q4 2012+1.7%
Q3 2012-2.6%
Q2 2012-1.7%
Q1 2012+3.8%
Q4 2011+2.3%
Q3 2011-2.2%
Q2 2011-1.7%
Q1 2011+0.5%
Q4 2010+0.7%
Q3 2010-0.5%
Q2 2010+1.6%
Q1 2009-0.8%
Q1 2010-0.2%
Q4 2009+0.4%
Q4 2007+0.4%
Q3 2008+5.5%
Q3 2009+5.5%
Q4 2008+1.3%
Q2 2008+1.3%
Q2 2009+1.3%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro